1.Effects of two different incision phacoemulsification on corneal astigmatism
Lu, HUO ; Xiao-Lin, HAO ; Zhong-Chen, ZHANG
International Eye Science 2014;(12):2198-2200
AlM:To compare the effect of different incision in corneal astigmatism after phacoemulsification.
METHODS: Totally 88 cases ( 122 eyes ) with pure cataract were randomly divided into two groups. Forty cases (60 eyes) were clarity corneal incision in group A, and 48 cases ( 62 eyes ) were sclera tunnel incision in group B. Mean corneal astigmatism, surgically induced astigmatism ( SlA ) , uncorrected visual acuity ( UCVA ) and best correct vision acuity ( BCVA ) were observed in pre- and post-operation at 1d;1wk;1mo.
RESULTS: The mean astigmatism had statistically significant difference between two groups at 1d; 1wk;1mo after operation(P<0. 05). The SlA had statistically significant difference at 1d ( P<0. 05 ); The SlA had no statistically significant difference between two groups at 1mo after operation (P>0. 05). UCVA≥0. 5 and BCVA≥0. 8 had statistically significant difference at 1d; 1wk ( P<0. 05) . There had no statistically significant difference at 1mo after operation (P>0. 05).
CONCLUSlON: Phacoemulsification with scleral tunnel incision remove combined intraocular lens ( lOL ) implantation has small changes to corneal astigmatism. By selecting personalized corneal incision according to the corneal topography might be more beneficial.
2.Clinical analysis of Peutz-Jeghers syndrome:a report of 6 cases.
Ke DONG ; Bo LI ; Ben-hai LI ; Quan-lin GUAN ; Yong-zhong HUO
Chinese Journal of Gastrointestinal Surgery 2005;8(4):336-338
OBJECTIVETo investigate the diagnostic methods and reasonable treatment of Peutz-Jeghers syndrome (PJS).
METHODSClinical data of six patients with PJS were reviewed.
RESULTSRepeated abdominal pain, intussusception and intestinal polyp with bleeding were main manifestations. Four patients father,three patients grandfather and one patients mother were diagnosed with PJS. Three patients had family history of cancer. Case 4 and case 5 underwent laparotomy for many times because of intussusceptions caused by polyps or recurrent abdominal pain. Case 1 and case 4 had polyps synchronous with adenoma, and case 2 had polyp with gastric cancer. Main treatment included polyp resection and partial small intestinal and colon resection.
CONCLUSIONSPatients with PJS have family history of cancer and a high incidence of polyp recurrence of small intestine. Surgical intervention is the first choice regimen. Surveillance should be emphasized on gastrointestinal tract and other potential malignant organs in PJS patients.
Adolescent ; Adult ; Female ; Humans ; Intestine, Small ; surgery ; Male ; Pedigree ; Peutz-Jeghers Syndrome ; diagnosis ; genetics ; surgery
3.Vardenafil significantly alleviates erectile dysfunction in aged men with diabetes.
Zhong-Lin ZHANG ; Huo-Jin LI ; Wan-Hua ZHEN ; Rong YUAN
National Journal of Andrology 2008;14(8):737-739
OBJECTIVETo observe the efficacy and safety of vardenafil in the treatment of erectile dysfunction (ED) in aged men with diabetes mellitus (DM).
METHODSOne hundred outpatients with diagnosed ED (40 diabetic and 60 non-diabetic) received vardenafil at the initial dose of 20 mg and sustained dose of 10 mg once a week for 8 weeks, and their erectile functions were evaluated by IIEF and EQS.
RESULTSThe scores on IIEF and EQS in the diabetic ED group were 18.9 +/- 0.2 and 25.1 +/- 1.4 after the vardenafil treatment, significantly higher than 8.1 +/- 0.5 and 9.1 +/- 1.3 before the treatment (P < 0.01), and the non-diabetic group scored 21.1 +/- 0.2 and 34.2 +/- 1.2 on IIEF and EQS after the treatment, as compared with the statistically lower scores of 10.1 +/- 0.3 and 10.1 +/- 1.7 before it (P < 0.01). The total rate of effectiveness was 65% in the diabetic and 73.30% in the non-diabetic group, with statistical differences (P < 0. 05).
CONCLUSIONVardenafil can significantly improve erectile function and is well tolerated in the aged males with diabetic ED.
Aged ; Aging ; physiology ; Diabetes Mellitus, Type 2 ; complications ; Erectile Dysfunction ; drug therapy ; etiology ; physiopathology ; Humans ; Imidazoles ; therapeutic use ; Male ; Middle Aged ; Phosphodiesterase Inhibitors ; therapeutic use ; Piperazines ; therapeutic use ; Sulfones ; therapeutic use ; Treatment Outcome ; Triazines ; therapeutic use ; Vardenafil Dihydrochloride
4.Neurotoxicity of homocysteine on murine hippocampal neuronal HT22 cells and the mechanisms
Jun LIU ; Song-Huo XIAO ; Zhong-Lin LIU ; Rui-Yan LU
Chinese Journal of Neuromedicine 2009;8(7):670-673
Objective To study the neurotoxicity of homocysteine (HCY) on routine hippocampal neuronal HT22 cells and investigate the mechanisms. Methods Differentiated HT22 cells were treated with different concentrations of HCY (0, 0.5, 1.0, 1.5, 2.0, and 2.5 mmol/L) in the presence or absence of NMDA antagonists MK801 and memantine. The cell viability was tested using MTS cytotoxicity assay. Hoechst 33342 and PI staining were used to observe the morphological changes of the cells. Results HCY induced concentration-dependent toxicity in HT22 cells with the 50% effective concentration (EC50>) of about 1.25 mmol/L. Administration of MKS01 and memantine significantly increased the cell viability, which reached the highest level after treatment with MKS01 and memantine at the concentration of 10 μmol/L (P<0.05). Hoechst 33342 and PI staining revealed obvious cell apoptosis at low HCY concentrations (1.0 mmol/L), while cell necrosis was obvious at a higher concentration (2.0 mmol/L). Conclusion HCY induced obvious concentration-dependent neurotoxicity in HT22 cells largely through the activation of NMDA receptors, and the interaction between HCY and the NMDA receptors may provides an important pathway for research of neuronal cell loss.
5.Orthodontic treatment of Class Ⅲ patients with mandibular asymmetry
Yin-Zhong DUAN ; Na HUO ; Lei CHEN ; Xue-Peng CHEN ; Yang LIN
Chinese Journal of Stomatology 2008;43(12):723-726
Objective To investigate the treatment outcome of Class Ⅲ patients with dental,functional and mild skeletal mandibular asymmetry.Methods Thirty-five patients(14 males and 21 females)with dental,functional and mild skeletal mandibular asymmetry were selected.The age range of the patients Was 7-22 years with a mean age of 16.5 years.Dental mandibular asymmetry was treated with expansion of maxillary arch to help the mandible returning to normal position.Funetional mandibular asymmetry Was treated with activator or asymmetrical protraction and Class Ⅲ elastics. Mild skeletal mandibular asymmetry Waft.treated with camouflage treatment.Results Good occlusal relationships were achieved and facial esthetics Was greatly improved after orthodontic treatment in patients with dental and functionsl mandibular asymmetry.However,patients with skeletal mandibular asymmetry should be treated with both extraction and genioplasty.Conclusions Orthedontic treatment was suitable for patients with dental and functional mandibular asymmetry,while combined orthodontics and surgery could get good results in patients with skeletal mandibular asymmetry.
6.Clinical study on YMDD mutation and pre-core C region and core promotor region mutation of the patients with chronic hepatitis B virus receiving lamivudine therapy
Cheng XU ; Hui-Lin YANG ; Lin-Mei XU ; Hong-Yan YAO ; Xiao-Hua LE ; Mei-Zhong LI ; Xiao-Ling JIANG ; Ju-Zhen ZHONG ; Min WANG ; Huo-Sheng WANG ; Boping ZHOU
Chinese Journal of Primary Medicine and Pharmacy 2006;0(07):-
Objective To mvesugate the Tate of YMDD mutation accompamed with pre-core(region and core promotor region mutation and the clinical significance.Methods YMDD mutation and pre-core(at 1896 nu- cleotide)region and core promotor region(at 1762.1764 nucleotide)mutation were detected from the 122 patients with chronic hepatitis B virus after receiving lamivudine treatment above 6 months.Results 40 cases were tested for YMDI)mutations in 122 HBV patients with lamivudine treatment,and the positive rate of YMDD mutation was 32.8 %.After YMDD mutation,ALT,AST and HBV DNA of the patients significantly increased(P0.05).Conclusion The patients with YMDD mutation had higher rate of pre-core region(at 1896 nucleotide)and basal core promotor region(at 1762, 1764 nucleotide)mutation than those without YMDD mutation,but there was no correlation between the mutation and the deterioration of disease condition and the bad prognosis.
7.The construction of a human serum albumin small gene.
Hong-mei ZHANG ; Xiao-ling JIANG ; Huo-sheng WANG ; Li-xiong LI ; Liu-mei XU ; Ping LIN ; Mei-zhong LI ; Min WANG ; Bo-ping ZHOU
Chinese Journal of Hepatology 2006;14(6):461-462
8.Oral propranolol in the management of periorbital proliferating phase infantile hemangioma.
Zhong-fang ZHAO ; Ren-rong LÜ ; Jian ZHANG ; Ran HUO ; Guang-qi XU ; Hong-bin FU ; Xuan GUO ; Jun-cheng WUI ; Ling-ling LIN
Chinese Journal of Plastic Surgery 2011;27(3):174-177
OBJECTIVETo observe the efficacy and safety of oral propranolol in the treatment of periorbital proliferating phase infantile hemangioma.
METHODSA retrospective review of patient medical records was performed. 12 patients (9 female, 3 male; 1.5-8.5 months, average 3.3 months) with periorbital proliferating phase infantile hemangioma underwent oral propranolol therapy. The dosage was slowly increased to 2 mg/kg daily in divided doses for a mean duration of 16 weeks (range 4 weeks-41 weeks). Therapeutic outcomes and safety were established by evaluating colour, size of lesion, duration of treatment and side-effects of treatment before and after treatment.
RESULTSOf these, 9 had a signification reduction in colour and size of the lesions, 2 had no further growth. 1 is stopped therapy due to hypotension after drug administration. 11 other patients, although mild adverse effects were noted, no symptoms were severe enough to discontinue treatment.
CONCLUSIONSPropranolol appears to be a safe and effective treatment in the management of periorbital proliferating phase infantile hemangioma.
Child ; Child, Preschool ; Female ; Hemangioma ; drug therapy ; Humans ; Infant ; Male ; Orbital Neoplasms ; drug therapy ; Propranolol ; administration & dosage ; therapeutic use ; Retrospective Studies ; Treatment Outcome
9.Identification and molecular cloning and sequence analysis of a novel coronavirus from patients with SARS by RT-PCR.
Bo-ping ZHOU ; Xin-chun CHEN ; Huo-sheng WANG ; Mei-zhong LI ; Yi-wen HU ; Fan DU ; Liu-mei XU ; Gui-lin YANG
Chinese Journal of Experimental and Clinical Virology 2003;17(2):137-139
OBJECTIVETo investigate the etiologic agents of the SARS and develop diagnostic method for this disease.
METHODSThirty-six nasopharyngeal aspirate specimens from 27 patients with SARS in Shenzhen were collected. The samples were aliquotted to three parts and subjected to molecular assays for human metapneumovirus, chlamydia and a novel coronavirus, which was reported recently to be the etiologic agent of SARS. Nested RT-PCR was used to amplify the RNA polymerase gene of the novel coronavirus and the PCR products were sequenced directly or after cloned to pMD18-T vector.
RESULTSHuman metapneumovirus and chlamydia genes were detected in none of the specimens using the RT-PCR and nested-PCR, respectively. The novel coronavirus gene were amplified in 6 of 36 specimens, the sequence analysis indicated that this novel coronavirus is unrelated to any other coronavirus reported previously. The nucleotide and deduced amino acid alignment between this coronavirus and others was not more than 40% and 70% to 82%, respectively, while the nucleotide sequence cloned from the 6 patients were identical.
CONCLUSIONSThe SARS patients in Shenzhen were infected with coronavirus and this novel coronavirus is associated with SARS. The sequence analysis indicated that the coronavirus from SARS patients in Shenzhen is the same as that identified from other areas such as Canada and Hong Kong. A specific diagnostic nested RT-PCR was developed to identify this novel coronavirus infection.
Adolescent ; Adult ; Aged ; Child ; Cloning, Molecular ; DNA, Viral ; genetics ; Female ; Genetic Variation ; Humans ; Male ; Middle Aged ; RNA, Viral ; genetics ; Reverse Transcriptase Polymerase Chain Reaction ; SARS Virus ; genetics ; isolation & purification ; Sequence Analysis, DNA ; Severe Acute Respiratory Syndrome ; virology
10.Forward genetic screening for zebrafish mutants defective in erythropoiesis.
Zhong-jun HUO ; Zong-hua WEN ; Jing LIN ; Kun WANG ; Zhi-bin HUANG ; Zhao-xia DAI ; Ning MA ; Guang YAN ; Ying-hua CHEN ; Xiao-hui CHEN ; Wei LIU ; Pin-yun MA ; Wei-hao LUO ; Ying ZHAO ; Shu FAN ; Jia-jia ZHAO ; Hong-hui HUANG ; Zi-long WEN ; Wen-qing ZHANG
Journal of Southern Medical University 2010;30(5):931-935
OBJECTIVETo screen and identify zebrafish mutants with erythropoiesis defects by N-ethyl-N-nitrosourea (ENU) mutagenesis and large-scale forward genetic screening using beta e 1 as the marker.
METHODSThe chemical mutagen ENU was used to treat healthy wild-type male fish (AB strain, F0). The surviving ENU-treated fish were mated with wild-type female fish to generate F1, and further F2 family was generated by F1 family intercross. The adult F2 fish were intercrossed within each F2 family and the resulting F3 embryos from each crossing were subjected to whole mount in situ hybridization (WISH) with the beta e 1 probe. Mutagenesis was performed by treating the male zebrafish with ENU to induce mutations in pre-meiotic germ cells to generate the founders, which were outcrossed to obtained the F1 fish. The F1 fish from different founders were mated to generate the F2 families. F3 embryos from the sibling cross in the F2 family were examined by whole mount in situ hybridization using beta e 1-globin probe. The putative mutants were then characterized with different hematopoiesis markers.
RESULTS AND CONCLUSIONWe identified 4 beta e 1-deficient mutants with erythropoiesis defects, including two with specific erythiod lineage defects and two with concurrent lymphopoiesis defects.
Animals ; Erythropoiesis ; genetics ; Ethylnitrosourea ; Female ; Gene Expression Regulation, Developmental ; Male ; Mutagenesis, Insertional ; Mutation ; Zebrafish ; genetics